Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study. (Q42645881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

9 March 2020

main subject

0 references

1 reference

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Michele Del Vecchio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ivana Krajsová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Bart Neyns

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Claus Garbe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ana Arance

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Paola Queirolo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Paolo Antonio Ascierto

3

object named as

Paolo A Ascierto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1

James Larkin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

10

Helen Gogas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

12

Mario Mandalà

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Vanna Chiarion Sileni

9

object named as

Vanna Chiarion Sileni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

13

Geke A P Hospers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

11

Wilson H Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

5

Jacob Schachter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

20

Christian U Blank

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

16

Axel Hauschild

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Enrique Espinosa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Lada Mitchell

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Luisa Veronese

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

27 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

436-444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Treatment of brain metastases in patients with melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Central nervous system involvement in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Second primary melanomas on treatment with vemurafenib.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Progression of RAS-mutant leukemia during RAF inhibitor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

Increased risk of second primary cancers after a diagnosis of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970051-8

7 January 2021

10.1016/S1470-2045(14)70051-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24582505%20AND%20SRC:MED&resulttype=core&format=json

release_sibavlutdvffhbebfacyr6zkae

9 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sibavlutdvffhbebfacyr6zkae

24 November 2022

mapped directly with Wikidata item

1 reference